Mumtaz Score for Readmission in Cirrhosis
The Mumtaz Score predicts 30‑day readmission risk in decompensated cirrhosis using demographics, comorbidities, complications, and key in‑hospital interventions 1 [Level II evidence].
사용 적응증
Used in hospitalized adults with decompensated cirrhosis at discharge to estimate 30‑day readmission risk based on demographics, decompensation features, and in‑hospital interventions. Derived from 123,011 patients and externally validated 1 [Level II evidence]. Helps stratify into low (<20%), medium (20–30%), and high (>30%) readmission risk to guide closer follow‑up and targeted post‑discharge interventions.
통찰 및 주의사항
Identifies 30‑day readmission risk in decompensated cirrhosis but has modest discrimination (c‑statistic ≈0.64–0.70) and relies on administrative data with limited clinical granularity 1 [Level II evidence].
• Overweights inpatient complications (HE, infections, HD) and may misclassify compensated or atypical phenotypes.
• Not externally validated in contemporary cohorts and may underperform across etiologies, frailty levels, and ambulatory settings.